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Abstract
BACKGROUND: The transnasal transsphenoidal endoscopic approach to the sella turcica is an overwhelming 
alternative to the microscopic approach for the past few decades assuming into prominence as a new technique, 
reaching nearly gold standard for this pathology. The endoscopic approach to the pituitary has redefined accurate 
visualization of the sella. The panoramic view afforded by the endoscope is unparalleled as compared with the 
traditional conical view of the microscope.
AIMS: This study aims to compare both endoscopic and microscopic technologies, including advantages and 
disadvantages through the results of endocrine outcome.
SETTINGS AND DESIGN: Our retrospective/prospective study included 46 microscopically and 39 endoscopically 
treated patients during the period of 2010–2018. Tumors were classified according to the diameter and clinical 
outcomes were evaluated.
RESULTS: Our retrospective/prospective study included 46 microscopically and 39 endoscopically treated 
patients during the period of 2010–2018. Tumors were classified according to the diameter, hormone activity and 
clinical outcomes were evaluated. Comparison results revealed more efficacious and effective endocrine control 
and reestablishing the endocrine homeostasis utilizing the endoscopic technique, especially in secretory active 
macroadenomas. Further, the extension of the resection, which was better in endoscopic approach undouptedly 
contributed to better endocrine control of the disease. Complication rate, including endocrine, was lower following 
endoscopy compared with microsurgery.
CONCLUSION: This technique evidenced to have a statistically significant reduction in operative time and length of 
hospital stay, as well as more radical safe resection and complication control. There is also a trend toward improved 
endocrine outcomes and rate of return of visual defects. These two approaches are still comparable with eloquent 
advantages and disadvantages, formulated as balanced dialectics. In addition, the use of endoscopes, including 
multilocular polifilament 3D endoscope, facilitates extended approaches, reaching a delicate skull base lesions that 
are suprasellar, retrosellar, and parasellar, which permits visualization beyond the abilities of the microscope.
Introduction
Pituitary adenoma is the third most common 
intracranial tumor in surgical practice, accounting for 
approximately 10–25% of all intracranial tumors [1]. 
Recent epidemiological data suggest that clinically 
apparent pituitary adenomas have a prevalence of 
1/1000 in the general population [2], [3]. Although 
only very rarely malignant, pituitary tumors may cause 
significant morbidity in affected patients where why they 
demand total resection, and their treatment remains 
challenge [4].
Transsphenoidal surgery of the pituitary 
evolves continually beginning from the early 20th century, 
initially assigned by Schmidt et al., which were the 
first to report a sellar tumor through transsphenoidal 
route in 1907 [5], [6]. Cushing successively focused 
and popularized sublabial transseptal transsphenoidal 
corridor in the following decades [7]. Abandoned for 
several decades, this technique revived with Hardy in the 
early 1960s, introducing the operative microscope nearly 
becomes a standard approach causes it provided minimal 
morbidity and mortality [8]. The rapid global expand in 
the past two–three decades emerged with Jankowski, 
who proposed fully endoscopic approach to pituitary 
lesions in 1992 [9]. The current high-tech development 
of optics, radiodiagnostics, high sensitivity radio essays, 
informatics, instrumentation, surgical devices, and utility 
tissue high-tech materials incorporated with human 
innate sickness for prospect, lead to milestone progress 
at this field. Endoscopic transsphenoidal surgery 
presents safe, efficacious, effective, and minimally 
invasive surgery of the pituitary, which allows surgeons 
to gain access to central skull base lesions in a secure 
manner defining probably the gold standard for the future.
Comprehensive cadaveric dissections, with 
3D evaluation in the learning curve of the pituitary 
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surgeons, provided meaningful baseline for expansion 
in this field [10].
The current endoscopes are two dimensional 
and cannot provide stereoscopic three-dimensional 
view compared with the operative microscope. This fact 
dictates evaluated equivocal rationale and balanced 
dialectics between these two technologies. The 
emerging new technology of 3D multilocular polifilament 
endoscopes supposed to overwhelm this insufficiency.
The purpose of this study was to compare the 
outcomes and the complications associated with these 
techniques by comparing endoscopic with microscopic 
surgery in the treatment of pituitary adenomas, 
emphasizing the endocrine aspect.
Materials and Methods
Our study included eighty-five patients 
harboring pituitary adenoma, operated in our institution 
during the period of 2011–2018. According to the 
technology, they were separated in two groups. The 
first group of 46 patients treated with transsphenoidal 
microscopic and endoscopically assisted microscopic 
technique and the second group of 39 patients operated 
on fully endoscopically.
Inclusion criteria
The following criteria were included in the 
study:
• Patients with adenoma over 14 years old
• Patients with clinically evident adenoma
• Patients with sellar lesion, according to the 
configuration, volume, and anatomy provide 
safe transsphenoidal endoscopic resection 
without distortion
• Intact diaphragm
• Patients with supra and parasellar lesion, 
previously assessed for two steps resection, 
initially transnasal
• Patients with microadenoma with Cushing 
disease
• Previously transsphenoidal microscopically 
operated patients with recurrens and clinical 
manifestation.
Exclusion criteria
The following criteria were excluded from the 
study:
• Patients bellow 14 years old
• Lesions unfavorable anatomically for safe 
endoscopic resection (kissing carotids, high 
suprasellar and/or parasellar, intraorbital 
propagation, or cavernous sinus engagement)
• Other histopathological lesions
• Microadenomas favorable for conservative 
treatment
• Previously endoscopically treated patients with 
evident complication and high risk
Comprehensive neurological examination 
including motor, sensory, and cranial nerve examination 
has been performed, including visual field, acuity, 
fundus, and evoked potentials. Routine blood and basic 
hormonal profile were performed. Magnetic resonance 
imaging (MRI) brain and paranasal sinuses including 
sella computed tomography (CT) were performed in 
all patients. All patients underwent the standardized 
microscopic or endoscopic procedure and were 
provided a uniform post-operative care.
All procedures were performed under general 
anesthesia with orotracheal intubation.
We used 4 mm diameter sinonasal rigid 
endoscope, “Karl Storz,” Tuttlingen, Germany, spheric 
0–0 and 30°. Initial phase was decongestive of the 
mucosa of the septum and turbinates. Consecutively, 
the middle meatus and sphenoid rostrum have been 
identified and drilled to enter the sphenoid. Delicate 
drilling was to open the sellar floor. The dura was 
opened in a crucial manner. Further, with delicate 
dissection with the pituitary instruments, the tumor has 
been removed, primarily posterior and superior aspect 
and finally lateral and anterior portion prospectively. 
Second, the tumor site, the sella has been inspected 
with a 30° endoscope. After the tumor resection, the 
basal cisternal arachnoid emerges downward pulsating. 
Hemostasis is completed usually with Surgiflo liquid 
surgical. The tumor cavity and sphenoid were packed 
with fat and sealed with fibrin glue. Nasal packing was 
done with Merocel up to the middle meatus. In most 
cases, lumbar drain has been placed for 72 h.
Microscopic surgery was standardized and 
similar, except introducing Hardy’s nasal speculum 
and done under visualization with a microscope pp 
“Pentero,” Zeiss, Germany.
The hormonal profile, highly sensitive assays, 
and visual function evaluation including VEP, MRI, 
and CT scanning were repeated immediately and 
after 1 month of surgery and were compared with pre-
operative findings, both for endoscopic and microscopic 
procedures.
Statistical analysis
Statistical analysis was performed with 
Statistica 7.1 for Windows and SPSS Statistics 23.0 
(SPSS Inc., Chicago, IL, USA).
The analysis of the patient series with attributes 
(gender, clinical diagnosis, pre-operative hormone 
activity, type of pre-operative hormone activities, 
quantity of resection of the lesion, post-operative assay 
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in secretory tumors, and the categorical data) were 
presented as numbers (percentage - %).
The differences between the two technologies 
(microscopic transsphenoidal and endoscopic 
transsphenoidal surgery) were compared using 
Pearson Chi-square test (p), Pearson’s Chi-square 
test/Monte Carlo sig. (p), and Fisher’s exact test/Monte 
Carlo sig. (p).
The cross-tabulation between the two groups 
has been performed with Pearson’s Chi-square test/
Monte Carlo sig. (p), and Fisher’s Exact Test/Monte 
Carlo Sig. (p).
Results
Within the group microscopically treated, 33 
were male and 13 female patients. Nineteen were male 
and 20 were female in the group treated endoscopically.
The mean age of the patients with microscopic 
procedure was 54.22 ± 12.64 years (ranged 28–75 
years).
The mean age of the patients endoscopically 
treated was 50.87 ± 12.65 years (ranged 12–72 years).
The results of the pre-operative hormone 
activities in both groups of pituitary adenomas are 
exposed in Table 1.
Table 1: Pre-operative hormone activities in both groups of 
pituitary adenomas
Variable Pre-operative hormone activity Total
Non-secretory (non-active) Secretory (active)
Procedure
Microscopic
Count 13 33 46
% 28.3 71.7 100.0
Endoscopic
Count 11 28 39
% 28.2 71.8 100.0
Total
Count 24 61 85
% 28.2 71.8 100.0
Within the group of 46 microscopically treated, 
13 (28.30%) were secretory non-active and 33 (71.70%) 
were functional, secretory active.
Within the group of 39 endoscopically treated, 
11 (28.20%) were preoperatively inactive, non-secretory 
and 28 (71.80%) were secreting active adenomas.
By Pearson’s Chi-square = 0.00 and p < 0.05 
(p = 0.99), no significant difference according to the 
secretory activity has been noted.
Compared results postoperatively, according 
to the radicality of resection associated with secretory 
active adenomas are revealed in Table 2.
In the group of 33 secretory active microscopically 
treated lesions, 5 (15.20%) remained unchanged, 
18 (54.50%) experienced partial non-significant 
improvement, 9 (27.30%) experienced significant 
improvement, and 1 (3.00%), the vision was normalized.
In the group of 28 secretory active 
endoscopically treated lesions, 13 (46.40%) post-
operative vision has been significantly improved and 15 
(53.60%) had normalization of the vision.
For Fisher’s exact test = 40.22 and p < 0.001 
(p = 0.000)/Monte Carlo sig./0.000–0.000/there is a 
significant difference in post-operative assay between 
the groups of hormone active lesions treated 
microscopically and endoscopically.
The results of the post-operative assay of the 
group with endocrine active lesion microscopically 
treated, associated with the quantity degree of resection 
are evident in Table 3.
In the group of 33 patients with hormonally active 
microscopically treated lesion, in 7 (21.21%), the resection 
has been achieved up to 50%, in 22 (66.67%) up to 75%, 
and in 4 (12.12%) subtotal resection up to 90%.
Postoperatively, within the group of 7 patients 
with resection up to 50%, in 4 (57.10%), the hormone 
activity remained unchanged, and in 3 (42.90%), the 
hormone activity improved partially.
In the same group, where the resection has 
been performed up to 75%, in 1 (4.50%) hormone 
activity remained unchanged, in 13 (59.10%) partially 
improved, in 7 (31.80%) significantly improved, and in 1 
(4.50%), the hormone activities have been normalized.
In four patients of this group, where the 
resection has been achieved up to 90%, in 2 (50.00%), 
the hormone activity has been partially improved and in 
2 (50.00%) significantly improved.
The cross-tabulation of the results between the 
degree quantity of resection and post-operative hormone 
activity for the lesions treated with transsphenoidal 
microscopic surgery for Fisher’s exact test = 11.43 and 
p < 0.05 (p = 0.033) / Monte Carlo sig./0.028–0.037/
delineated significant difference.
The group of 28 patients with pre-operative 
secretory active adenomas, treated with transsphenoidal 
endoscopic resection, comprised 10 (35.71%) with 
subtotal resection up to 90% and 18 (64.29%) with 
resection over 90%.
Postoperatively, of the subgroup with subtotal 
resection up to 90%, in 7 (70.00%), the hormone 
Table 2: Postoperatively results, according to the radicality of 
resection associated with secretory active adenomas
Variable Post-operative assay in hormone secretory adenomas Total
Significant improvement Normalized
Radicality of resection
Up to 90%
Count 7 3 10
% 70.0 30.0 100.0
Over 90%
Count 6 12 18
% 33.3 66.7 100.0
Total
Count 13 15 28
% 46.4 53.6 100.0
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activity was significantly improved and in 3 (30.00%) 
normalized.
The compared results of post-operative 
hormone assay of the two groups of patients treated 
microscopically and endoscopically are exposed in 
Table 4.
Table 4: Results of post-operative hormone assay of the two 
groups of patients treated microscopically and endoscopically
Variable Post-operative assay in secretory active adenomas Total
Unchanged Partially 
improved
Significantly 
improved
Normalized
Procedure
Microscopic
Count 5 18 9 1 33
% 15.2 54.5 27.3 3.0 100.0
Endoscopic
Count 0 0 13 15 28
% 0.0 0.0 46.4 53.6 100.0
Total
Count 5 18 22 16 61
% 8.2 29.5 36.1 26.2 100.0
In 33 patients microscopically treated, 
5 (15.20%) remained unchanged, 18 (54.50%) 
experienced partial improvement, 9 (27.30%) 
experienced significant improvement, and in 1 (3.00%), 
post-operative secretory activity was normalized.
In 28 patients endoscopically treated, 13 
(46.40%) experienced significant improvement, and in 
15 (53.60%), the post-operative hormone activity was 
normalized.
The Fisher’s exact test = 40.22 and p < 0.001 
(p = 0.000)/Monte Carlo Sig./0.000–0.000 depicted 
significant difference in the outcome pp post-operative 
hormone assay in the compared groups treated 
microscopically and endoscopically.
Discussion
Pituitary tumors surgery still represent a 
significant challenge, despite the highly refined nature, 
evolved high technology, informatics, and training 
and learning advance of the contemporary micro 
and endoscopic surgery. The endoscope as a device 
introduced to this technology has been widely accepted 
for the past three decades. High technology evolution 
of the optics provides progressive trends toward 
less invasive approach. Evidently, the endonasal 
endoscopic approach is less invasive, efficacious, safe, 
and effective to the pituitary gland and local surrounding 
structures, supplemented with better intraoperative 
illumination, image, angle, and wideness of surgical 
and working field.
Guiot is the recognized first pioneering 
surgeon introducing endoscope in transsphenoidal 
approach [11].
Reisch et al. defined that the endoscope 
contributes to comprehensive panorama to the anatomy, 
introducing the concept of minimally invasive surgery 
[12]. Song et al., in 1992, introduced the fully endoscopic 
concept as an approach to sellar region [13].
Keyworth et al. with largest prospective study 
series (215 patients) and Khan et al., with series of 
170 patients traced the pathway of this technology as 
dominant and safe [14], [15].
First comparison between microscopic and 
endoscopic technique performed by Khan et al., in a 
retrospective study in 1999 [2], [15].
Yadav et al., presented comparison of the two 
technologies with evident improvement and advance of 
the transsphenoidal endoscopic versus transsphenoidal 
microscopic technology, concerning visuality, quantity 
of resection, and complication control [16].
Schwartz et al. proceeded step forward, 
defining the concept of balanced dialectics of both 
technologies.
Endoscopic transsphenoidal pituitary surgery 
is developing technique becoming nearly standard 
procedure for pituitary lesions, and consequent 
comparison with microscopic transsphenoidal surgery is 
and will be committed only to delineate the advantages 
and disadvantages.
Table 3: Post-operative assay of the group with endocrine active lesion microscopically treated, associated with the quantity degree 
of resection
Variable Post-operative assay in secretory active adenomas Total
Unchanged Partially improved Significantly improved Normalized
Type of hormone activity preoperatively
STH secretory
Count 0 7 1 0 8
% 0.0 87.5 12.5 0.0 100.0
PLC secretory
Count 3 1 0 0 4
% 75.0 25.0 0.0 0.0 100.0
ACTH secretory
Count 0 1 0 0 1
% 0.0 100.0 0.0 0.0 100.0
TSH secretory
Count 0 0 1 0 1
% 0.0 0.0 100.0 0.0 100.0
STH, PLC secretory
Count 2 9 7 1 19
% 10.5 47.4 36.8 5.3 100.0
Total
Count 5 18 9 1 33
% 15.2 54.5 27.3 3.0 100.0
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Three-dimensional visuality and almost 
unnecessary additional training for microneurosurgeons 
are still the advance.
On the other hand, endoscope provides full 
exquisite panorama of the surgical site, minimal damage 
to the nasal cavity, no invisible angle, better illumination, 
better vision and distinguisability of the lesion surface, 
better bleeding control, better bimanual manipulation, 
no speculum, in addition much wider surgical operating 
field better resection, less complication, less operative 
time, and early discharge.
Certainly, learning curve and process of 
training much more demand for this technology.
Furtheron, introducing the multifocal 
multifilament endoscope as a technological 
innovation provides 3D vision of the surgical field, 
eliminating the handicap compared to 3D operative 
microscope.
In our study, we present a comparison of these 
two technologies, the ability and quantity of resection, 
associated with endocrine function outcome compared 
pre- and postoperatively.
In the present study, there was safer and 
significantly more radical resection accomplished within 
the group endoscopically treated, consequently with 
better endocrine outcome and less complication.
This result is entirely compatible with the 
recent studies, pp previous prospective study done 
by Jain et al. who concluded less post-operative 
complication, less operative time in endoscopic 
transsphenoidal group as compared to transsphenoidal 
microscopic technology.
Conclusion
For the past decades, the endoscopic 
transsphenoidal pituitary surgery becomes a 
milestone in operative treatment of pituitary lesions 
mostly comprising adenomas. It provides direct 
endonasal minimally invasive corridor, panoramic 
view inside the sphenoid cavity, and sella. Endoscopic 
transsphenoidal pituitary adenoma surgery is defined 
as safe, efficacious, effective, minimally invasive, 
with wider and direct anatomical control of the 
operative field, better illumination, wide angle without 
blind angle field, resulting with greater, faster and 
safer potential of tumor excision with respect to 
the sphenoid, and sellar and parasellar anatomical 
structures. Conclusively, higher possibility and 
potential for more radical resection provided better 
general outcome result and free of disease interval 
including much better in our study, endocrine overall 
outcome.
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